New Raumedic leadership duo to intensify market focus

Stefan Seuferling (links), der neue Vorstandsvorsitzende der Raumedic AG, und Martin Bayer, CEO und Präsident der US-Gesellschaft, wollen sich stärker auf die Bedürfnisse ihrer Zielmärkte konzentrieren. / Stefan Seuferling (left), the new Chairman of the Executive Board of Raumedic AG, and Martin Bayer, CEO and President of the U.S. business operation, plan to focus more closely on the needs of their target markets.

The medical technology manufacturer Raumedic has re-assigned responsibilities among its top management team. Executive Board member Stefan Seuferling has been named Chairman of the Executive Board of Raumedic AG by the company’s Board of Directors in a decision that took effect March 15. Martin Bayer, the former Chairman of the Executive Board of the Raumedic Group, will focus on his function as CEO and President of the U.S. associated company Raumedic Inc. in order to develop business in North America, the world’s largest medical technology market.

Think globally, act locally

Jürgen Werner, the Chairman of the Board of Directors, said the decision was designed to improve the position of the company in the respective markets. “Medical technology and the pharmaceutical industry face different requirements in each economic region,” Werner said. “In addition, customers are approaching Raumedic with highly individual product requests. With the new management structure, we want to enable both companies to retain their flexibility and to be highly responsive to their respective markets.”

As the highest oversight authority for both companies, the Board of Directors works closely with the management team to ensure that the principle of “One Raumedic” is systematically applied, Werner said in describing the new structure. 

Executive Board under new leadership

Stefan Seuferling joined Raumedic AG in September 2018 as the Executive Board member responsible for strategy, from which position he leads sales activities in Europe and Asia. He also oversees the departments of Marketing Communication, Quality Management, Regulatory Affairs, as well as Projects & Services. Together with his Executive Board colleagues, Seuferling will lead the business activities of Raumedic AG as Chairman of the Executive Board.

Closer to the world’s largest medical technology market

As part of the efforts of Raumedic to enter the world’s largest medical technology and pharmaceutical market, Martin Bayer moved his office to Mills River, North Carolina, in spring of 2018. Bayer, who has extensive experience in the medical technology market, intends to generate the same success in the USA that he produced for the global organization: Under his leadership, both sales and staffing nearly doubled from 2008 to 2018.

“The new leadership team is the next logical step in our efforts to make Raumedic increasingly agile and market-centric,” Chairman of the Board of Directors Jürgen Werner said. “We have the utmost confidence in Stefan Seuferling and Martin Bayer. We are certain that they can help the entire company continue generating sustainable and profitable growth. With this goal in mind, they will remain in close dialogue in the future.”